Contrast Injector Systems Market Research, 2030
The global contrast injector systems market was valued at $755.57 million in 2020, and is projected to reach $1.5 billion by 2030, growing at a CAGR of 7.3% from 2021 to 2030. A contrast injector system is a medical diagnostic device that makes use of a contrast media to create visual representations of the interior of the human body to diagnose, monitor, or treat clinical disorders. The key imaging process includes, computed tomography, magnetic resonance imaging, and angiography. The contrast media enhances the contrast structures or visibility of fluids within the body as compared to traditional image processing. For instance, it is used to improve the visibility of blood vessels and gastrointestinal tract. These systems include various components, such as injector systems, consumables, and accessories. Consumables consist of injector head, syringes, tubing, and other consumables, whereas, accessories consist of hand switch, extension cable, face plate assembly, pressure jacket, syringe assembly, heater blanket assembly, coiled hand switch, and remote hand switch bracket.
Contrast injector system is expected to exhibit significant market growth during the forecast period, owing to increase in imaging procedures and rapid incidence of various chronic diseases, such as cancer, heart diseases, Alzheimer’s, and dementia. The key factors that drive the growth of market increase in geriatric population coupled with high prevalence of chronic diseases globally. However, high cost of contrast injectors systems and high risk associated with contrast injector system are expected to restrict the market growth. Moreover, surge in healthcare expenditure and emergence of complex diseases in developing countries are expected to create lucrative opportunities for key market players.
The contrast injector system market is segmented on the basis of product type, application, end user, and region. According to product type, the market is divided into injector systems, consumables, and accessories. On the basis of application, the market is divided into interventional radiology, interventional cardiology, and radiology. On the basis of end user, the market is divided into diagnostic centers, clinics, hospitals, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA).
By Product Type
Injector Systems segment was the leading segment during forecast period.
Product Type Segment Review
By type, the contrast injector system market is divided into injector systems, consumables, and accessories. The consumables segment was the major revenue contributor in 2020, and is anticipated to continue this trend during the forecast period, owing to the growth in number of imaging procedures, such as CT, MRI, and angiography. On the other side, the demand for injector system is projected to exhibit the fastest market growth during the forecast period, owing to rise in incidence of chronic ailments such as various types of cancer, Alzheimer’s, and dementia, and other diseases, which is expected to create a demand for diagnostic procedures for precise treatment.
By Application
Interventional Radiology segment would exhibit a CAGR of 8.6% during forecast period.
Application Segment Review
By application, the contrast injector systems market size classified as interventional radiology, interventional cardiology, and radiology. The interventional radiology segment presently dominates the contrast injector systems market size, and is expected to remain dominant during the forecast period. This segment is expected to exhibit a prominent growth of contrast injector systems market share, owing to reduced risks, lower cost, and higher level of comfort, shorter hospital stays, and quicker recover. In addition, different diagnostic procedures that can be performed using interventional radiology include, angiography, cholangiography, and biopsy.
By End User
Diagnostics centers segment was the leading segment during forecast period.
End User Segment Review
By end user, the contrast injector systems industry is classified as diagnostic centers, clinics, hospitals, and others. The hospitals segment presently dominates the contrast injector systems market forecast, and is expected to remain dominant during the forecast period. This segment is expected to exhibit a prominent growth rate of contrast injector systems market opportunity owing to adoption of latest imaging technologies at the earliest to offer effective examination of functional areas, which were not visible by older or conventional technologies. These factors are driving the contrast injector systems market growth.
By Region
Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 8.1% during the forecast period.
Region Segment Review
By region, the contrast injector system market is analyzed across North America, Asia-Pacific, Europe, and LAMEA. North America dominated the contrast injector systems industry in 2020, accounting for the highest contrast injector systems market share, and is anticipated to maintain this trend during the forecast period. The research activities for contrast injector system are soaring in North America, owing to the well-established healthcare facilities, recent technological advancements, and rise in demand for early diagnosis of chronic diseases due to increase in awareness regarding contrast injectors.
This report provides comprehensive competitive analysis and profiles of prominent market players, such as key players operating in Bracco Imaging S.p.A, Bayer HealthCare, Guerbet Group, Medtron AG, Ulrich GmbH & Co. KG, GE Healthcare, Shenzhen Seacrown Electromechanical Co., Ltd., Nemoto Kyorindo Co. Ltd., Sino Medical- Device Technology Co., Ltd., and Vivid Imaging.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the contrast injector systems market analysis from 2020 to 2030 to identify the prevailing contrast injector systems market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the contrast injector systems market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global contrast injector systems market trends, key players, market segments, application areas, and market growth strategies.
Contrast Injector Systems Market Report Highlights
| Aspects | Details |
 Market Size By 2030 | USD 1.5 billion |
 Growth Rate | CAGR of 7.3% |
 Forecast period | 2020 - 2030 |
 Report Pages | 212 |
 By Product Type |
|
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | Bayer Healthcare LLC, Shenzhen Seacrown Electromechanical Co., Ltd., Ulrich GmbH & Co. KG, Sino Medical- Device Technology Co., Ltd., Nemoto Kyorindo Co. Ltd., Bracco Imaging S.p.A, Vivid Imaging, Medtron AG, GE Healthcare, Guerbet Group |
Analyst Review
Utilization of contrast injector system is expected to witness significant growth in the near future, owing to increase in diagnosis of chronic diseases. Contrast injector systems are gaining traction among healthcare providers, as they offer benefits for the diagnosis and treatment of clinical disorders coupled with evolving indications of these systems.
Significant technological advancements in contrast injector systems lead to the provision of advanced treatment options for the management of chronic disease patients. The demand for contrast injector systems is on a continuous rise, due to surge in geriatric population prone to chronic diseases and increase in number of diagnostic procedures globally. As the market is saturated and growing at a steady rate in developed nations, the Asia-Pacific and LAMEA regions are expected to offer ample growth opportunities to key players in the market.
Escalation in incidence of chronic diseases, such as cancer and various heart ailments and increased emphasis on early prevention are some of the major factors that drive the market growth. However, high cost of the injector systems and certain side effects of the contrast media hamper the contrast injector systems market growth to some extent.
Currently, by product type, consumables is the largest segment in terms of revenue for contrast injector systems market, attributed to increase in occurrence of chronic diseases patients as the mean age of the global population shifts toward older age groups and hectic lifestyle leading to stress in daily life, which increases with the number of procedures conducted. In addition, CT injector system accounted for the highest share in 2016, owing to rapid CT scanner installations and increase in number of diagnostic imaging processes.
This is specifically due to the high demand for CT scans for neuroimaging with contrast injectors, as these are best suited for neurological investigations, such as intracranial hemorrhage, brain injuries, tumor, and acute neurological changes.
Moreover, emerging markets gain importance for majority of the contrast injector system manufacturers and distributors, as they focus towards unmet demand for diagnosing diseases in these regions. Hence, many companies have started introducing technologically advanced products to cater the needs of the rise in population, especially in developing economies. For instance, Bracco Imaging launched injector systems for personalized patient care and reduced cost savings in 2016. The novel software-enabled contrast injector systems not only track patients’ current health status, but also alert the physician for any adverse reactions. Rapid growth was observed in the shipments of these devices to provide improved healthcare services in emerging nations, and this is expected to offset the challenging conditions in mature markets, such as North America and Europe. North America is expected to dominate the global contrast injector system market during the forecast period, followed by Europe.
the trends of Contrast Injector Systems Market are rise in incidence of chronic ailments such as various types of cancer, Alzheimer’s, and dementia, and other diseases, which is expected to create a demand for diagnostic procedures for precise treatment.
The leading application of Contrast Injector Systems Market are interventional radiology, interventional cardiology, and radiology.
North America is the largest regional market for Contrast Injector Systems.
Contrast Injector Systems Market is projected to reach $ 1529.38 million by 2030, registering a CAGR of 7.3% from 2021 to 2030.
The top companies to hold the market share in Contrast Injector Systems are Bracco Imaging S.p.A, Bayer HealthCare, Guerbet Group, Medtron AG, Ulrich GmbH & Co. KG, GE Healthcare, Shenzhen Seacrown Electromechanical Co., Ltd., Nemoto Kyorindo Co. Ltd., Sino Medical- Device Technology Co., Ltd., and Vivid Imaging.
Loading Table Of Content...
Loading Research Methodology...
